Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Asia Regulatory News (AAS)

Share Price Information for Aberdeen Asia (AAS)

Share Price is delayed by 15 minutes
Get Live Data
440.00    0.00 (0.00%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £609.09m
AAS Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Asia Share Chart

Portfolio Disclosures

9 Dec 2025 14:09

RNS Number : 8779K
Aberdeen Asia Focus plc
09 December 2025
 

Availability of Portfolio Data on Websites

 

9 December 2025

 

abrdn Holdings Limited announces that the unaudited Portfolio Holding Summary of the following investment company, as at 30 November 2025, is now available on the company's website, within the "Literature Library" under the Key Documents section. Unless otherwise disclosed financial assets have been valued on a fair value basis using bid prices, or, if more appropriate, a last trade basis:

 

Aberdeen Asia Focus PLC

Legal Entity Identifier: 5493000FBZP1J92OQY70

 

www.aberdeeninvestments.com/aas

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCPKCBPNBDDCBK
Date   Source Headline
10th Mar 20265:05 pmRNSTransaction in Own Shares
10th Mar 20265:05 pmRNSTransaction in Own Shares
10th Mar 202611:34 amRNSNet Asset Value(s)
9th Mar 20261:07 pmRNSGearing Disclosures
9th Mar 20261:07 pmRNSGearing Disclosures
9th Mar 202611:46 amRNSNet Asset Value(s)
6th Mar 202612:24 pmRNSNet Asset Value(s)
5th Mar 20265:05 pmRNSTransaction in Own Shares
5th Mar 20262:00 pmRNSMonth End Net Asset Value(s)
5th Mar 202611:50 amRNSNet Asset Value(s)
4th Mar 202611:10 amRNSNet Asset Value(s)
3rd Mar 20265:07 pmRNSTransaction in Own Shares
3rd Mar 202610:50 amRNSNet Asset Value(s)
2nd Mar 20262:55 pmRNSGearing disclosure
27th Feb 202612:26 pmRNSNet Asset Value(s)
26th Feb 202612:25 pmRNSNet Asset Value(s)
25th Feb 202612:08 pmRNSNet Asset Value(s)
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 202612:38 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 202612:21 pmRNSNet Asset Value(s)
18th Feb 202611:00 amRNSNet Asset Value(s)
17th Feb 20264:00 pmRNSCompliance with Market Abuse Regulation
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:40 amRNSPortfolio disclosure
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 20264:14 pmRNSHolding(s) in Company
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 202612:22 pmRNSNet Asset Value(s)
11th Feb 202610:26 amRNSSecond Interim Dividend
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 20266:00 pmRNSQuarterly Disclosures
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20264:20 pmRNSHolding(s) in Company
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 202610:22 amRNSTotal Voting Rights
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 202611:46 amRNSNet Asset Value(s)
26th Jan 20262:37 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.